The EU has been pushing for a six to 10 years’ data exclusivity period, which would prevent India from using an innovator's ...
The 2026 revision of the Implementing Regulation of the Drug Administration Law, effective May 15, 2026, was recently passed by China’s State Council.
On 4 June 2025, the Council of the EU adopted its position on the EU Pharma Law Package legislative proposal to revise the EU’s general pharmaceutical legislation. The Council, consisting of all the ...
One of India's biggest drugs companies is urging the government to change the rules on data exclusivity, saying the country needs to balance the interests of multinational pharmaceutical companies and ...
Windtree Therapeutics, Inc. announced that it has received guidance from intellectual property and FDA experts regarding a potential strategy for its drug istaroxime, which targets cardiogenic shock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results